Christophe Bourdon

Christophe Bourdon

Director/Board Member at SWEDISH ORPHAN BIOVITRUM AB
56 year
Health Technology
Consumer Services
Health Services

Profile

Christophe Bourdon is Chief Executive Officer at LEO Pharma A since 2022.
Mr. Bourdon is Director at Swedish Orphan Biovitrum AB since 2023.
Former roles include Chief Executive Officer at Strategic Partners A from 2021 to 2022, Senior Vice President & General Manager-US Oncology at Amgen, Inc. from 2020 to 2021, and Senior VP-Europe, Middle East, Africa & Canada at Alexion Pharmaceuticals, Inc. from 2015 to 2017.
Education includes an MBA from International Institute for Management Development and an undergraduate degree from Institut Supérieur de Gestion.

Christophe Bourdon active positions

CompaniesPositionStart
SWEDISH ORPHAN BIOVITRUM AB Director/Board Member 01/01/2023
Chief Executive Officer 01/01/2022

Former positions of Christophe Bourdon

CompaniesPositionEnd
STRATEGIC PARTNERS A/S Chief Executive Officer 01/04/2022
AMGEN INC. Corporate Officer/Principal 01/03/2021
ALEXION PHARMACEUTICALS, INC. Corporate Officer/Principal 01/11/2017
See the detail of Christophe Bourdon's experience

Training of Christophe Bourdon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

60

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Health Services

Consumer Services

Health Technology

Health Technology

Consumer Services

  1. Stock Market
  2. Insiders
  3. Christophe Bourdon
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!